Mercer Global Advisors’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,325
| Closed | -$39K | – | 2065 |
|
|
2023
Q1 | $39K | Sell |
5,325
-94
| -2% | -$688 | ﹤0.01% | 1879 |
|
|
2022
Q4 | $36K | Buy |
5,419
+94
| +2% | +$624 | ﹤0.01% | 1883 |
|
|
2022
Q3 | $54K | Hold |
5,325
| – | – | ﹤0.01% | 1764 |
|
|
2022
Q2 | $65K | Buy |
5,325
+4,566
| +602% | +$55.7K | ﹤0.01% | 1757 |
|
|
2022
Q1 | $16K | Buy |
759
+23
| +3% | +$485 | ﹤0.01% | 1859 |
|
|
2021
Q4 | $44K | Sell |
736
-600
| -45% | -$35.9K | ﹤0.01% | 1754 |
|
|
2021
Q3 | $125K | Hold |
1,336
| – | – | ﹤0.01% | 1666 |
|
|
2021
Q2 | $221K | Hold |
1,336
| – | – | ﹤0.01% | 1521 |
|
|
2021
Q1 | $257K | Buy |
+1,336
| New | +$257K | ﹤0.01% | 1382 |
|